The Society of Urologic Oncology Clinical Trials Consortium (SUO-CTC) helps to improve research options, which ultimately deliver better quality of life to patients with urologic cancers.
Defining High Bleeding Risk in Patients Undergoing Percutaneous
Webinar: Expanding Treatment Options for Non-muscle Invasive
Molecular Therapy - Methods & Clinical Development
Advancing CAR T cell therapy through the use of multidimensional
ASCO GU 2023: Outcomes by IMDC Risk in the COSMIC-313 Phase 3
The Lancet Commission on the future of care and clinical research
Panel Discussion on Cxbladder Genomic Urine Test for Bladder Cancer
Clinically Localized Prostate Cancer: AUA/ASTRO Guideline (2022
The Suo Research Lab
Society of Urologic Oncology :: Home